Koers Nextgen Biomed Ltd TEL AVIV STOCK EXCHANGE
Aandelen
IL0010839301
Medische apparatuur, benodigdheden & distributie
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 27,18 mln. 10,07 mld. 25,26 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -2 mln. -741 mln. -1,86 mln. | Nettowinst (verlies) 2022 | -8 mln. -2,96 mld. -7,43 mln. | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 11,96 mln. 4,43 mld. 11,11 mln. | Nettoliquiditeiten 2022 | 5,24 mln. 1,94 mld. 4,87 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-21,7
x | K/w-verhouding 2022 |
-3,17
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 92,33% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 20-11-22 | |
Dalia Mulakandov
DFI | Director of Finance/CFO | 39 | 17-01-23 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 08-08-00 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Grossman
BRD | Director/Board Member | 49 | 12-06-22 |
Yaacov Amidror
CHM | Chairman | 76 | 07-01-21 |
Alon Pinkas
BRD | Director/Board Member | 62 | 17-11-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,40% | 27,92 mld. | |
-30,75% | 3,08 mld. | |
-15,97% | 2,53 mld. | |
+18,11% | 2,47 mld. | |
+7,78% | 2,1 mld. | |
-9,47% | 1,91 mld. | |
-0,56% | 1,51 mld. | |
+2,24% | 1,34 mld. | |
+24,32% | 1,24 mld. |